One initiative will equip research centres to use Claude to predict drug candidates for treating HPV and preeclampsia, diseases that have been less commercially attractive for pharmaceutical companies to research
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.






